Wylie W. Vale

Wylie W. Vale's AcademicInfluence.com Rankings

Wylie W. Vale

Biology

#1074

World Rank

#1848

Historical Rank

Neuroscience

#68

World Rank

#72

Historical Rank

Biochemistry

#71

World Rank

#91

Historical Rank

biology Degrees

Download Badge

Biology

Wylie W. Vale's Degrees

PhD Biochemistry University of California, San Francisco
Bachelors Chemistry University of California, Berkeley

Why Is Wylie W. Vale Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wylie W. Vale's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin (1981) (3784)
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing (1983) (2215)
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. (1983) (2004)
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor (1995) (1494)
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. (1984) (1484)
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. (1987) (1474)
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. (1977) (1323)
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress (2006) (1270)
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. (1982) (1234)
CRF and CRF receptors: role in stress responsivity and other behaviors. (2004) (1206)
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid (1986) (1181)
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour (1982) (1061)
The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization (1992) (1021)
Expression cloning of a human corticotropin-releasing-factor receptor. (1993) (920)
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor (2001) (907)
Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors (2001) (886)
Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules (2009) (878)
Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development (1998) (856)
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress (2000) (835)
A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence (1989) (789)
Corticotropin releasing factor produces behavioural activation in rats (1982) (747)
Expression cloning of an activin receptor, a predicted transmembrane serine kinase (1991) (731)
Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. (1982) (667)
Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. (1983) (571)
Betaglycan binds inhibin and can mediate functional antagonism of activin signalling (2000) (568)
Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. (1985) (556)
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. (1982) (556)
In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. (1982) (552)
Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. (1988) (549)
Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. (1986) (544)
Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin (1983) (539)
Structural basis of BMP signalling inhibition by the cystine knot protein Noggin (2002) (530)
Culture of Enzymatically Dispersed Anterior Pituitary Cells: Functional Validation of a Method (1972) (522)
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. (1994) (501)
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. (1995) (492)
β-ENDORPHIN AND ADRENOCORTICOTROPIN ARE SECRETED CONCOMITANTLY BY THE PITUITARY GLAND (1978) (482)
Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. (1984) (474)
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study (1985) (473)
Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A (1993) (467)
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. (1984) (465)
Chemical and biological characterization of the inhibin family of protein hormones. (1988) (459)
Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress (1991) (448)
Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. (1987) (448)
The neurobiology of depression: inroads to treatment and new drug discovery. (2005) (440)
Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. (1983) (427)
Corticotropin Releasing Factor Receptors and Their Ligand Family (1999) (422)
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. (1993) (415)
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. (1984) (408)
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). (1972) (406)
Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. (1977) (406)
Primary structure of corticotropin-releasing factor from ovine hypothalamus. (1981) (405)
Regional distribution of neurotensin and somatostatin in rat brain (1977) (403)
Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide (1983) (379)
Chemical and biological characterization of corticotropin releasing factor. (1983) (379)
Influence of corticotropin-releasing factor on reproductive functions in the rat. (1984) (371)
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus (1982) (364)
Characterization of rat hypothalamic growth hormone-releasing factor (1983) (361)
Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin‐Containing Projections With Targets Bearing Type 2 CRF Receptors (1999) (360)
Regulatory peptides of the hypothalamus. (1977) (358)
Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. (1971) (354)
Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. (1982) (348)
Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins (1991) (348)
Characterization of Ovine Hypothalamic Hypophysiotropic TSH-releasing Factor (1970) (344)
Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro (1978) (344)
International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands (2003) (341)
Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). (1984) (333)
Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta (1987) (328)
Characterization of a teleost gonadotropin-releasing hormone. (1983) (323)
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats (1983) (320)
Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus. (1986) (320)
Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. (1983) (316)
Cloning and characterization of human urocortin. (1996) (307)
Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant (1991) (303)
Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor (1983) (302)
Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat (1984) (300)
Characterization of rat hypothalamic corticotropin-releasing factor. (1983) (299)
The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. (1992) (292)
Purification and partial characterization of inhibin from porcine follicular fluid. (1985) (292)
Effects of somatostatin on the secretion of thyrotropin and prolactin. (1974) (291)
Bombesin:potent effects on thermoregulation in the rat. (1977) (288)
The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. (1989) (287)
Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat (1983) (286)
Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. (1987) (282)
Importance of FSH-releasing protein and inhibin in erythrodifferentiation (1987) (275)
In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. (1989) (273)
Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. (1982) (272)
Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like Behavior (2002) (270)
HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MAN (1983) (270)
Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids. (1984) (265)
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease (1986) (263)
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. (1981) (263)
Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. (1982) (262)
Localization, secretion, and action of inhibin in human placenta. (1987) (262)
Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. (1982) (259)
Production and regulation of inhibin subunits in pituitary gonadotropes. (1989) (259)
The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. (2003) (259)
Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. (1981) (258)
Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. (1984) (256)
Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. (1983) (250)
Stimulation of adenosine 3',5'-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. (1983) (249)
Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. (1988) (247)
Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. (1983) (244)
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. (1983) (242)
Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat. (1977) (242)
Structure of the ternary signaling complex of a TGF-β superfamily member (2006) (241)
Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells (1984) (241)
Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1 1 Published on the World Wide Web on 27 November 1998. 1 (1999) (238)
Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression (2002) (237)
The hypothalamic arcuate nucleus-median eminence complex: Immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons (1986) (235)
The Inhibin/Activin Family of Hormones and Growth Factors (1990) (234)
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. (1982) (234)
Corticotropin Releasing Factor (CRF) Binding Protein: A Novel Regulator of CRF and Related Peptides (1995) (230)
Characterization of melanin-concentrating hormone from rat hypothalamus. (1989) (230)
Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. (1974) (228)
Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antagonist properties. (1973) (226)
Glucocorticoid toxicity in the hippocampus: in vitro demonstration (1988) (223)
Corticotropin releasing factor (CRF) receptor antagonist blocks activating and ‘anxiogenic’ actions of CRF in the rat (1986) (222)
In the rat, interleukin-1 alpha acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. (1989) (219)
Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. (1992) (218)
Antagonists of activin signaling: mechanisms and potential biological applications (2005) (217)
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. (1981) (217)
Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism (1987) (216)
Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. (1994) (216)
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. (1995) (215)
[38] Assay of corticotropin releasing factor (1983) (215)
Inhibin A-subunit cDNAs from porcine ovary and human placenta. (1986) (209)
Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat. (1986) (207)
The functional neuroanatomy of corticotropin-releasing factor. (2007) (206)
Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood (1983) (204)
Hormonal regulation of granulosa cell inhibin biosynthesis. (1986) (203)
Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. (1990) (202)
Inhibition of growth hormone release in humans by somatostatin. (1973) (200)
Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. (1985) (199)
Rapid Changes in the Expression of Inhibin α-, βA-, and βB-Subunits in Ovarian Cell Types During the Rat Estrous Cycle (1988) (199)
Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. (1984) (196)
Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats (1999) (195)
Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. (1989) (194)
Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. (1984) (193)
Nonpeptidal peptidomimetics with a β-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist (1992) (192)
Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. (2011) (192)
NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. (2004) (192)
Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor. (1983) (191)
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. (1983) (189)
Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. (1994) (189)
The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone. (1973) (187)
Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion. (1985) (187)
Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. (1993) (186)
Bombesin affects the central nervous system to produce hyperglycemia in rats. (1977) (186)
Bombesin-like activity: radioimmunologic assessment in biological tissues. (1978) (186)
Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels. (1976) (184)
Cardiac inotropic actions of urocortin in conscious sheep. (1997) (182)
Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. (1986) (181)
Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation (1997) (178)
In the Rat, Interleukin- lα and -β Stimulate Adrenocorticotropin and Catecholamine Release* (1989) (175)
High affinity binding sites for a somatostatin-28 analog in rat brain. (1981) (174)
Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling* (2003) (174)
Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. (1977) (173)
GRP78 and Cripto Form a Complex at the Cell Surface and Collaborate To Inhibit Transforming Growth Factor β Signaling and Enhance Cell Growth (2007) (173)
Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro. (1978) (173)
Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. (1989) (172)
Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. (1981) (172)
Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. (1984) (171)
Increased Depression-Like Behaviors in Corticotropin-Releasing Factor Receptor-2-Deficient Mice: Sexually Dichotomous Responses (2003) (170)
Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior (2002) (170)
Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins. (1996) (168)
Biologic and immunologic activities and applications of somatostatin analogs. (1978) (166)
Desensitization to gonadotropin-releasing hormone observed in superfused pituitary cells on Cytodex beads. (1981) (166)
Thyrotropin-releasing hormone—CNS action to stimulate gastric acid secretion (1980) (166)
Inhibin β in central neural pathways involved in the control of oxytocin secretion (1988) (166)
EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCY (1983) (165)
Six novel gonadotropin-releasing hormones are encoded as triplets on each of two genes in the protochordate, Ciona intestinalis. (2003) (163)
Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide (2004) (163)
Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood. (1982) (163)
Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion (1985) (161)
Chronic effects of [D-Trp6-Pro9-NEt]luteinizing hormone-releasing factor on reproductive processes in the female rat. (1978) (161)
Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways (2009) (161)
Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin (2004) (161)
Detection and purification of inhibin using antisera generated against synthetic peptide fragments. (1989) (159)
Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. (2002) (159)
Anatomic and phylogenetic distribution of somatostatin. (1976) (157)
Regulation of Leydig cell function in primary culture by inhibin and activin. (1989) (157)
Type 1 corticotropin‐releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligand‐receptor mismatch in the central corticotropin‐releasing factor system (2008) (156)
Cripto forms a complex with activin and type II activin receptors and can block activin signaling (2003) (156)
Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. (1984) (155)
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. (2002) (154)
Differential production and regulation of inhibin subunits in rat testicular cell types. (1989) (154)
Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats (1985) (153)
Inhibition of growth hormone secretion in the rat by synthetic somatostatin. (1974) (151)
Acceleration of growth in two children treated with human growth hormone-releasing factor. (1985) (151)
Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF. (1984) (151)
Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats (1987) (150)
Diminished responsiveness of the hypothalamic-pituitary-adrenal axis of the rat during exposure to prolonged stress: a pituitary-mediated mechanism. (1987) (150)
Evidence for multifactor regulation of the adrenocorticotropin secretory response to hemodynamic stimuli. (1985) (149)
Brain regulation of gastric secretion: influence of neuropeptides. (1980) (147)
Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. (1982) (147)
Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. (1999) (146)
Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor (1983) (145)
Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide (2002) (145)
Smad8 mediates the signaling of the receptor serine kinase (1997) (145)
Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. (1990) (145)
Central nervous system effects of hypothalamic peptides. (1975) (144)
Human placenta and fetal membranes express human urocortin mRNA and peptide. (1996) (143)
Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells. (1983) (142)
Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation (2007) (140)
Superfusion of rat anterior pituitary cells attached to Cytodex beads: validation of a technique. (1980) (140)
Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. (1991) (140)
Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. (1996) (140)
Hormonal regulation of inhibin production by cultured Sertoli cells (1987) (139)
The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress (2006) (138)
Evidence for immunoreactive neurotensin in dog intestinal mucosa. (1976) (138)
Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage. (1991) (138)
Age-dependent changes in physiological action, content, and immunostaining of inhibin in male rats. (1988) (137)
Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. (1983) (137)
Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo. (1984) (136)
Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist (2003) (136)
Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. (2004) (135)
Corticotropin-Releasing Factor and Urocortin I Modulate Excitatory Glutamatergic Synaptic Transmission (2004) (135)
Distribution of corticotropin-releasing factor in rat brain. (1985) (134)
Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels. (1992) (132)
Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. (2003) (132)
Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat (1990) (129)
Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor (1985) (129)
Gonadal and extragonadal expression of inhibin a , 13 A , and BB subunits in various tissues predicts diverse functions (128)
New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. (1986) (128)
A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. (2004) (128)
Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. (1985) (128)
Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand (2007) (127)
Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. (1989) (126)
Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. (1984) (126)
Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. (1999) (125)
Ligand requirements of the human corticotropin-releasing factor-binding protein. (1995) (125)
The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. (1980) (124)
The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. (2004) (124)
Corticotropin-Releasing Factor Receptors CRF1 and CRF2 Exert Both Additive and Opposing Influences on Defensive Startle Behavior (2004) (124)
Increased pituitary sensitivity to glucocorticoid feedback during the stress nonresponsive period in the neonatal rat. (1986) (123)
D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. (1975) (123)
TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. (1973) (123)
Inhibin production by primary Sertoli cell-enriched cultures: regulation by follicle-stimulating hormone, androgens, and epidermal growth factor. (1988) (122)
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats (2005) (122)
Selective Activation of Corticotropin-Releasing Factor-2 Receptors on Neurochemically Identified Neurons in the Rat Dorsal Raphe Nucleus Reveals Dual Actions (2004) (122)
Activin and its receptors during gastrulation and the later phases of mesoderm development in the chick embryo. (1995) (121)
Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. (1970) (120)
Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. (1993) (120)
Corticotropin-Releasing Factor (CRF) Family of Ligands and Their Receptors (2004) (120)
Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations (1985) (120)
Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids. (1985) (119)
Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing Factor (1972) (119)
Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. (1993) (119)
The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. (1977) (119)
The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. (1986) (119)
Immunoneutralization of endogenous inhibin modifies hormone secretion and ovulation rate in the rat. (1989) (118)
Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis (2007) (117)
Effect of prenatal exposure to ethanol on the activity of the hypothalamic-pituitary-adrenal axis of the offspring: Importance of the time of exposure to ethanol and possible modulating mechanisms (1990) (117)
Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain (1986) (117)
Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. (1986) (116)
Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis. (1985) (115)
Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization (1990) (115)
Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. (2002) (115)
Central corticotropin-releasing factor suppresses natural killer cytotoxicity (1987) (114)
Pancreatic immunoreactive somatostatin release. (1977) (113)
Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. (1983) (112)
Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. (1991) (112)
Pituitary actions of ligands of the TGF-β family: activins and inhibins (2006) (111)
Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function. (1985) (111)
Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. (2002) (111)
Binding sites for growth hormone releasing factor on rat anterior pituitary cells (1985) (111)
Presence and synthesis of inhibin subunits in human decidua. (1990) (110)
Structure of the human melanin concentrating hormone mRNA. (1990) (110)
Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. (1991) (109)
Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. (1998) (109)
Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated (1997) (109)
Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. (1993) (109)
FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription* (2009) (109)
Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy (1987) (108)
Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor. (1982) (106)
Corticotropin-Releasing Factor (CRF) Sensitization of Ethanol Withdrawal-Induced Anxiety-Like Behavior is Brain Site Specific and Mediated by CRF-1 Receptors: Relation to Stress-Induced Sensitization (2010) (106)
Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. (1992) (105)
Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. (2004) (105)
Comparison of the biologic actions of corticotropin-releasing factor and sauvagine (1982) (104)
Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. (1992) (104)
Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. (1996) (103)
Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. (1984) (103)
Dissociation of Locomotor Activation and Suppression of Food Intake Induced by CRF in CRFR1-Deficient Mice. (2000) (102)
Roles of pathway-specific and inhibitory Smads in activin receptor signaling. (1999) (101)
Ovine corticotropin-releasing factor stimulates somatostatin secretion from cultured brain cells. (1983) (101)
Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. (1984) (101)
Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin. (1984) (101)
Isolation and characterization of somatostatin from pigeon pancreas. (1979) (99)
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. (1993) (99)
Actions of bombesin, thyrotropin releasing factor, prostaglandin E2 and naloxone on thermoregulation in the rat. (1977) (99)
The effect of bombesin and related peptides on prolactin and growth hormone secretion in the rat. (1978) (99)
Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. (2004) (99)
Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. (1985) (99)
Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. (1992) (98)
Localization and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. (1991) (97)
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. (1981) (96)
Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization (2002) (96)
A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. (2005) (96)
Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. (1997) (96)
Somatostatin-28: selective action on the pancreatic beta-cell and brain. (1981) (96)
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. (1998) (95)
CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. (1999) (95)
Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line. (1993) (95)
Immunostainable inhibin subunits are in multiple types of testicular cells. (1989) (94)
Structural Basis of BMP Signaling Inhibition by Noggin, a Novel Twelve-Membered Cystine Knot Protein (2003) (94)
Evidence for a physiological role of gonadotropin-releasing hormone (GnRH) or GnRH-like material in the ovary. (1985) (94)
Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. (2005) (94)
Desensitization to growth hormone-releasing factor (GRF) is associated with down-regulation of GRF-binding sites. (1986) (93)
125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. (1996) (93)
Analysis of peptide histidine-isoleucine/ vasoactive intestinal polypeptideimmunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor-and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus (1987) (93)
Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor. (1984) (92)
Somatostatin: analogs with selected biological activities. (1977) (92)
Novel Subunit-Specific Tonic GABA Currents and Differential Effects of Ethanol in the Central Amygdala of CRF Receptor-1 Reporter Mice (2013) (91)
Urocortin 2-Deficient Mice Exhibit Gender-Specific Alterations in Circadian Hypothalamus–Pituitary–Adrenal Axis and Depressive-Like Behavior (2006) (91)
Structure-activity relationships of mammalian, chicken, and salmon gonadotropin releasing hormones in vivo in goldfish. (1985) (91)
Delayed Satiety-Like Actions and Altered Feeding Microstructure by a Selective Type 2 Corticotropin-Releasing Factor Agonist in Rats: Intra-Hypothalamic Urocortin 3 Administration Reduces Food Intake by Prolonging the Post-Meal Interval (2007) (91)
Activin-A modulates growth hormone secretion from cultures of rat anterior pituitary cells. (1990) (91)
The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action. (1987) (91)
A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery (2010) (91)
Rat melanin-concentrating hormone messenger ribonucleic acid expression: marked changes during development and after stress and glucocorticoid stimuli. (1992) (91)
Corticotropin-releasing factor receptors in rat pituitary gland: autoradiographic localization (1984) (91)
Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation (2012) (90)
An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonist. (1991) (89)
Radioligand assay for gonadotropin-releasing hormone: relative potencies of agonists and antagonists. (1980) (89)
Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. (2003) (88)
Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat. (1986) (88)
Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist. (1983) (87)
Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists. (1983) (87)
Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. (1996) (87)
Alpha 2-macroglobulin is a binding protein of inhibin and activin. (1993) (87)
Brain distribution of radioimmunoassayable gonadotropin-releasing hormone in female goldfish: seasonal variation and periovulatory changes. (1987) (87)
Urocortin 3 Marks Mature Human Primary and Embryonic Stem Cell-Derived Pancreatic Alpha and Beta Cells (2012) (86)
Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides. (1986) (86)
Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. (1996) (86)
Multiple forms of somatostatin-like activity in rat hypothalamus. (1980) (86)
Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. (1987) (85)
Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. (1993) (85)
Activins and the receptor serine kinase superfamily. (1995) (85)
Isolation and characterization of somatostatin from anglerfish pancreatic islet. (1979) (85)
Human Urocortin II, a Selective Agonist for the Type 2 Corticotropin-Releasing Factor Receptor, Decreases Feeding and Drinking in the Rat (2003) (84)
Novel Hypothalamic and Preoptic Sites of Prepro‐Melanin‐Concentrating Hormone Messenger Ribonucleic Acid and Peptide Expression in Lactating Rats (1992) (84)
Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. (2000) (84)
The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum. (1989) (84)
Effects of transforming growth factors and inhibin-related proteins on rat preovulatory graafian follicles in vitro. (1989) (83)
Cloning and characterization of human urocortin. (2013) (83)
Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. (1988) (82)
Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids. (2006) (82)
Cripto/GRP78 modulation of the TGF‐β pathway in development and oncogenesis (2012) (82)
In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I (1983) (82)
Desensitization of cultured pituitary cells to gonadotropin-releasing hormone: Evidence for a post-receptor mechanism (1983) (82)
Subtype-Selective Corticotropin-Releasing Factor Receptor Agonists Exert Contrasting, but Not Opposite, Effects on Anxiety-Related Behavior in Rats (2007) (82)
Somatostatin: central nervous system actions on glucoregulation. (1979) (82)
Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells. (1972) (81)
Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat (2002) (81)
Activins and Inhibins and Their Signaling (2004) (81)
Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins? (1991) (81)
Inhibin: studies of stored and secreted forms by biosynthetic labeling and immunodetection in cultured rat granulosa cells. (1988) (81)
Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test (2004) (81)
Molecular Cloning of a Novel Type I Receptor Serine/Threonine Kinase for the TGFβ Superfamily from Rat Brain (1996) (80)
Effects of γ-Aminobutyric Acid and Histamine on Prolactin Secretion in the Rat (1977) (80)
Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions. (2006) (79)
Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study. (1992) (79)
Behavioral Effects of Central Administration of The Novel CRF Antagonist Astressin in Rats (2000) (79)
Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. (1990) (78)
Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. (1984) (78)
Neuroendocrinology of the human placenta (1990) (78)
Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. (1989) (78)
Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. (1990) (77)
Interaction between ethanol and stress on ACTH and beta-endorphin secretion. (1988) (77)
Gonadotropin-releasing hormone, inhibin, and activin in human placenta: evidence for a common cellular localization. (1992) (77)
Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. (1999) (77)
Isolation and characterization of hypothalamic growth-hormone releasing factor from common carp, Cyprinus carpio. (1992) (77)
Synthesis and relative potencies of new constrained CRF antagonists. (1993) (77)
Molecular cloning and binding properties of the human type II activin receptor. (1992) (77)
The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin. (1998) (77)
Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors. (1982) (76)
Influence of the frequency of ovine corticotropin-releasing factor administration on adrenocorticotropin and corticosterone secretion in the rat. (1983) (76)
Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. (1999) (76)
Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. (1994) (76)
Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation. (1982) (75)
Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor* (2001) (75)
Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. (1996) (75)
Functional relationship between receptor binding and biological activity for analogs of mammalian and salmon gonadotropin-releasing hormones in the pituitary of goldfish (Carassius auratus). (1989) (75)
Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. (1985) (75)
Corticotropin-Releasing Factor and Parturition: Plasma and Amniotic Fluid Levels and Placental Binding Sites (1990) (75)
Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor (1983) (75)
Central nervous system inhibition of gastric secretion in the rat by gastrin-releasing peptide, a mammalian bombesin. (1981) (75)
Receptor for calcitonin gene-related peptide: binding to exocrine pancreas mediates biological actions. (1985) (74)
Effects of [D-Arg6, Trp7, Leu8, Pro9NEt]-luteinizing hormone-releasing hormone (sGnRH-A) and [D-Ala6, Pro9NEt]-luteinizing hormone-releasing hormone (LHRH-A), in combination with pimozide or domperidone, on gonadotropin release and ovulation in the Chinese loach and common carp. (1988) (74)
Why Men Die Younger : Causes of Mortality Differences by Sex (74)
Somatostatin analogs inhibit somatostatin secretion from cultured hypothalamus cells. (1984) (74)
Characterization of type II activin receptors. Binding, processing, and phosphorylation. (1993) (74)
Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. (1984) (74)
Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle (2006) (73)
Characteristics of the pituitary binding sites for thyrotropin releasing factor. (1973) (73)
Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. (2004) (73)
Growth hormone-releasing factor stimulates pancreatic enzyme secretion. (1984) (72)
Molecular characterization of rat transforming growth factor-β type II receptor (1993) (72)
Urocortins in human reproduction (2004) (71)
Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling (2006) (71)
Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation. (1984) (71)
Adenosine 3',5'-monophosphate, prostaglandins, and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. (1987) (71)
The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: implications for a role for betaglycan in inhibin-mediated reproductive functions. (2002) (71)
Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan (2001) (70)
Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. (2004) (70)
Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. (1993) (69)
Characterization of gonadotropin-releasing hormone (GnRH) binding to pituitary receptors in goldfish (Carassius auratus). (1987) (69)
Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. (1989) (69)
PHARMACOLOGY OF HYPOTHALAMIC REGULATORY PEPTIDES (1976) (68)
CRFR1 is expressed on pancreatic β cells, promotes β cell proliferation, and potentiates insulin secretion in a glucose-dependent manner (2009) (68)
Antireproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat. (1980) (68)
Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. (1994) (68)
Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurons of the rat di- and telencephalon (1987) (68)
Chronic exposure of cultured rat anterior pituitary cells to GRF causes partial loss of responsiveness to GRF. (1984) (68)
In vitro responses of rainbow trout (Oncorhynchus mykiss) somatotrophs to carp growth hormone-releasing factor (GRF) and somatostatin. (1990) (68)
Assay of corticotropin releasing factor. (1983) (67)
An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors* (2004) (67)
Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. (1987) (67)
Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion. (1989) (67)
Immunohistological localization of growth hormone-releasing hormone in human tumors. (1985) (67)
Chronic Cocaine Administration Switches Corticotropin-Releasing Factor2 Receptor-Mediated Depression to Facilitation of Glutamatergic Transmission in the Lateral Septum (2005) (67)
Immunohistochemical study of neurons containing corticotropin‐releasing factor in Alzheimer's disease (1987) (66)
Pituitary binding sites for ( 3 H)-labelled luteinizing hormone releasing factor (LRF). (1973) (66)
Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and Nodal* (2008) (66)
Regulation of Corticotropin-Releasing Factor Receptor Type 2β Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines. (2000) (66)
The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone. (1983) (66)
[D-pGlu1,D-Phe2,D-Trp3,6]-LRF. A potent luteinizing hormone releasing factor antagonist in vitro and inhibitor of ovulation in the rat. (1978) (66)
Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis. (2010) (65)
Activin at Parturition: Changes of Maternal Serum Levels and Evidence for Binding Sites in Placenta and Fetal Membranes (1994) (65)
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist * † (1993) (65)
Activin-A modulates gonadotropin-releasing hormone secretion from a gonadotropin-releasing hormone-secreting neuronal cell line. (1991) (65)
Binding sites for calcitonin gene-related peptide in distinct areas of rat brain (1985) (65)
Coexistence of tyrosine hydroxylase and growth hormone-releasing factor in a subpopulation of tubero-infundibular neurons of the rat. (1986) (64)
The hormonal actions of corticotropin-releasing factor in sheep: effect of intravenous and intracerebroventricular injection. (1983) (64)
Central activin administration modulates corticotropin-releasing hormone and adrenocorticotropin secretion. (1991) (64)
Acceleration of Growth Rate in Growth Hormone-Deficient Children Treated with Human Growth Hormone-Releasing Hormone (1988) (64)
Biological effects of cysteamine: relationship to somatostatin depletion (1983) (64)
Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. (1990) (64)
Inhibition of vasopressin-induced ACTH release from the pituitary by glucocorticoids in vitro. (1968) (64)
Corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in rat pituitary: localization and regulation by immune challenge, restraint stress, and glucocorticoids. (2003) (63)
Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. (1984) (63)
Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat. (1976) (63)
Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localization. (1985) (63)
Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. (1999) (63)
Secretion of melanin-concentrating hormone and neuropeptide-EI from cultured rat hypothalamic cells. (1992) (63)
Inhibin: measurement and role in the immature female rat. (1987) (63)
In vivo stimulation of prolactin secretion in the rat by thyrotropin releasing factor, related peptides and hypothalamic extracts. (1974) (62)
Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow. (1985) (62)
Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin. (1984) (61)
Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient (2001) (61)
Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras. (2000) (61)
Synthetic TRF (thyrotropin releasing factor) analogues. II. pGlu-N3imMe-His-Pro-NH2: a synthetic analogue with specific activity greater than that of TRF2. (1971) (61)
Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure (1997) (61)
Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. (2006) (61)
Common and divergent structural features of a series of corticotropin releasing factor-related peptides. (2007) (61)
Corticotropin releasing factor (CRF) immunoreactivity in hypothalamic and extrahypothalamic nuclei of sheep brain. (1983) (61)
Widespread expression of corticotropin-releasing factor messenger RNA and immunoreactivity in the rat olfactory bulb (1989) (60)
Synthetic thyrotropin-releasing factor analogs. 3. Effect of replacement or modification of histidine residue on biological activity. (1972) (60)
A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men. (1989) (60)
Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. (2006) (60)
Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat. (1999) (59)
Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol. (1983) (59)
High affinity GNRH binding to testicular membrane homogenates. (1980) (59)
Paradoxical activational effects of a corticotropin-releasing factor-binding protein “ligand inhibitor” in rat brain (2000) (59)
Dissociation of the adrenocorticotropin secretory responses to corticotropin-releasing factor (CRF) and vasopressin or oxytocin by using a specific cytotoxic analog of CRF. (1988) (59)
Inactivation of activin-dependent transcription by kinase-deficient activin receptors. (1995) (59)
Muscarinic cholinergic stimulation of somatostatin secretion from long term dispersed cell cultures of fetal rat hypothalamus: inhibition by gamma-aminobutyric acid and serotonin. (1983) (59)
Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist. (1983) (58)
Urocortin Messenger Ribonucleic Acid: Tissue Distribution in the Rat and Regulation in Thymus by Lipopolysaccharide and Glucocorticoids1. (1999) (58)
Rat anterior pituitary folliculostellate cells are targets of interleukin-1beta and a major source of intrapituitary follistatin. (2003) (58)
High affinity binding sites for somatostatin to rat pituitary. (1982) (58)
Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy. (1989) (58)
Expression of CRF1 and CRF2 receptors in human cancers. (2003) (58)
Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle. (1984) (58)
Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect. (1981) (58)
Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats (1985) (57)
Differential suppression of follicle-stimulating hormone and luteinizing hormone secretion in vivo by a gonadotropin-releasing hormone antagonist. (1985) (57)
Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity (2004) (57)
Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro. (1995) (57)
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. (1989) (56)
Immunoreactivities for antisera to three putative neuropeptides of the rat melanin-concentrating hormone precursor are coexpressed in neurons of the rat lateral dorsal hypothalamus (1992) (56)
Inhibin/activin subunits are costored with FSH and LH in secretory granules of the rat anterior pituitary gland. (1992) (56)
Regulation of ACTH Secretion from Corticotrophs: The Interaction of Vasopressin and CRF a (1987) (56)
Actions of agonistic and antagonistic analogs of gonadotropin releasing hormone (Gn-RH) in the bullfrog Rana catesbeiana. (1982) (56)
erbB2 is required for G protein-coupled receptor signaling in the heart (2006) (56)
Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus. (1973) (56)
Calcitonin gene-related peptide acts within the central nervous system to inhibit gastric acid secretion (1984) (56)
Photo-cross-linkers incorporated into G-protein-coupled receptors in mammalian cells: a ligand comparison. (2011) (55)
On the Mechanism of Action of TRF: Effects of Cycloheximide and Actinomycin on the Release of TSH Stimulated in Vitro by TRF and its Inhibition by Thyroxine (1968) (55)
Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies. (1989) (55)
High molecular weight somatostatin secretion by cultured rat brain cells (1982) (55)
Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations. (1985) (54)
The univin gene encodes a member of the transforming growth factor-beta superfamily with restricted expression in the sea urchin embryo. (1994) (54)
Changes in hypothalamic, limbic and extrapyramidal somatostatin levels following various hypothalamic transections in rat (1980) (54)
Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. (1986) (53)
Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. (2011) (53)
Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling (2006) (53)
A Soluble Form of the First Extracellular Domain of Mouse Type 2β Corticotropin-releasing Factor Receptor Reveals Differential Ligand Specificity* (2003) (53)
Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: circular dichroism and prediction studies. (1983) (53)
Phorbol ester-induced down-regulation of protein kinase C abolishes vasopressin-mediated responses in rat anterior pituitary cells. (1987) (53)
Smad7 inhibits mesoderm formation and promotes neural cell fate in Xenopus embryos. (1998) (53)
Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men. (1985) (53)
Effect of a potent GnRH antagonist and testosterone propionate on mating behavior and fertility in the male rat. (1981) (52)
Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus. (2003) (52)
Ovulatory and steroidal responses in the lamprey following administration of salmon gonadotropin and agonistic and antagonistic analogues of gonadotropin-releasing hormone (1983) (52)
Beta-endorphin regulation of FSH-stimulated inhibin production is a component of a short loop system in testis. (1987) (52)
Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men. (1986) (51)
Corticotropin-releasing factor as a transmitter in the human olivocerebellar pathway (1987) (51)
Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence. (1983) (51)
Investigation of larger forms of somatostatin in pigeon pancreas and rat brain. (1978) (51)
Bombesin — a putative mammalian neurogastrointestinal peptide (1979) (51)
Abnormalities in Corticotropin‐releasing Hormone (CRH) in Alzheimer's Disease and Other Human Disorders a (1987) (50)
Surface properties of an amphiphilic peptide hormone and of its analog: corticotropin-releasing factor and sauvagine. (1983) (50)
Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. (1970) (50)
Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. (2003) (50)
Reproductive/endocrine and anaphylactoid properties of an LHRH-antagonist, ORF 18260 [Ac-DNAL1(2), 4FDPhe2,D-Trp3,D-Arg6]-GnRH. (1985) (50)
Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor. (1994) (50)
Identification of a Functional Binding Site for Activin on the Type I Receptor ALK4* (2003) (49)
Regulation of corticotropin-releasing factor mRNA in neuroendocrine and autonomic neurons by osmotic stimulation and volume loading. (1992) (49)
Brain regulation of gastric acid secretion in rats by neurogastrointestinal peptides (1981) (49)
Growth hormone-releasing factor stimulation test in depression. (1988) (49)
Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation (2008) (48)
Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon [proceedings]. (1976) (48)
Expression of the type II activin receptor gene in the human placenta. (1993) (48)
Possible role of luteinizing hormone and follicle-stimulating hormone in modulating inhibin secretion and expression during the estrous cycle of the rat. (1989) (48)
Hypothalamic Hypophysiotropic Hormones (1975) (48)
Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man. (1983) (48)
Effect of recombinant activin-A on gonadotropin secretion in the female rat. (1991) (47)
Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. (1986) (47)
Response of pancreatic immunoreactive somatostatin to arginine. (1976) (47)
Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. (1997) (47)
Presence, actions, and regulation of myostatin in rat uterus and myometrial cells. (2009) (47)
Effect of recombinant inhibin on luteinizing hormone and follicle-stimulating hormone secretion in the rat. (1991) (47)
NOCTURNAL PULSATILE GROWTH HORMONE RELEASING HORMONE TREATMENT IN GROWTH HORMONE DEFICIENCY (1986) (46)
Local extragonadal roles of activins (1992) (46)
Polymer‐based cell‐free expression of ligand‐binding family B G‐protein coupled receptors without detergents (2011) (46)
Response of superfused goldfish pituitary fragments to mammalian and salmon gonadotropin-releasing hormones. (1984) (46)
Carbon monoxide modulates secretion of corticotropin-releasing factor from rat hypothalamic cell cultures (1994) (46)
Modulation of activin and BMP signaling (2004) (46)
Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. (1991) (46)
Chemistry of the hypothalamic releasing factors--studies on structure-function relationships. (1973) (45)
Somatostatin content of the median eminence in female rats with lesion-induced disruption of the inhibitory control of growth hormone secretion. (1978) (45)
Ovulation and embryo recovery rates following immunization of mares against an inhibin alpha-subunit fragment. (1992) (45)
Effects of porcine follicular fluid, inhibin-A, and activin-A on goldfish gonadotropin release in vitro. (1992) (45)
Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP) (1993) (45)
Effects of naloxone on anti-conflict and hyperphagic actions of diazepam. (1981) (45)
Adenovirus‐mediated overexpression of follistatin enlarges intact liver of adult rats (2003) (45)
β-lipotropin-β-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression : preliminary studies (1990) (45)
High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor. (1997) (45)
Orientation restrictions of the peptide hormone, thyrotropin-releasing factor, due to intramolecular hydrogen bonding. (1972) (45)
Regulation of corticotropin-releasing factor secretion in vitro by glucose. (1988) (45)
Pituitary actions of ligands of the TGF-beta family: activins and inhibins. (2006) (45)
Regulation and Actions of Smad7 in the Modulation of Activin, Inhibin, and Transforming Growth Factor-β Signaling in Anterior Pituitary Cells. (2001) (45)
Co-localization of neuroactive substances in the endocrine hypothalamus. (1992) (45)
Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man. (1984) (44)
Neurotensin and substance-P: effects on plasma insulin and glucagon levels. (1976) (44)
Gonadotropin-releasing hormone antagonists: novel members of the azaline B family. (1995) (44)
Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides. (1983) (44)
Hormonal secretion in male rats chronically treated with [D-Trp6, Pro9-NEt]-LRF. (1979) (44)
Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men. (1983) (44)
Applications of adenohypophyseal cell cultures to neuroendocrine studies. (1976) (43)
Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men. (1988) (43)
Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes. (2009) (43)
Autoradiographic localization of somatostatin receptors in rat brain. (1984) (43)
Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges. (1997) (43)
Human pancreatic growth hormone-releasing factor (hpGRF) stimulates growth hormone release in goldfish. (1984) (43)
Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. (1975) (43)
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase. (1997) (43)
Antireproductive effects of a potent GnRH antagonist in the female rat. (1981) (42)
Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion? (1981) (42)
The gonadotropin-releasing hormone pituitary receptor interacts with a guanosine triphosphate-binding protein: differential effects of guanyl nucleotides on agonist and antagonist binding. (1989) (42)
Pharmacology of thyrotropin releasing factor (TRF), luteinizing hormone releasing factor (LRF), and somatostatin. (1977) (42)
Periovulatory Changes in the Expression of Inhibin α-, βA-, and βB-Subunits in Hormonally Induced Immature Female Rats (1989) (42)
Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. (2002) (42)
Activin inhibits binding of transcription factor Pit-1 to the growth hormone promoter. (1992) (42)
In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. (1971) (42)
The Role of Corticotropin-Releasing Factor Receptors in Stress and Anxiety1 (2002) (42)
Growth hormone release in the rat: effects of somatostatin and thyrotropin-releasing factor. (1975) (42)
Somatostatin analogs inhibit somatostatin release. (1979) (42)
Regulation of Follicle-Stimulating Hormone Secretion by the Interactions of Activin-A, Dexamethasone and Testosterone in Anterior Pituitary Cell Cultures of Male Rats (2003) (42)
The effect of LHRH antagonist analogs and an antibody to LHRH on mating behavior in female rats (1981) (42)
Ovine genomic urocortin: cloning, pharmacologic characterization, and distribution of central mRNA. (1999) (42)
Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. (1989) (42)
Phorbol diesters stimulate somatostatin secretion from cultured brain cells. (1983) (42)
Identification of corticotropin-releasing factor (CRF) target cells and effects of dexamethasone on binding in anterior pituitary using a fluorescent analog of CRF. (1986) (42)
Identification and characterization of a pituitary corticotropin-releasing factor binding protein by chemical cross-linking. (1987) (41)
New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist. (1993) (41)
A new cytotoxin specific for the target cells of corticotropin-releasing factor. (1987) (40)
Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin (2012) (40)
Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan. (2010) (40)
Residues of Corticotropin Releasing Factor-binding Protein (CRF-BP) That Selectively Abrogate Binding to CRF but Not to Urocortin 1* (2008) (40)
Forces and structural limitations of binding of thyrotrophin-releasing factor to the thyrotrophin-releasing receptor: the pyroglutamic acid moiety. (1977) (40)
Comparison of [D-Arg6, Trp7, Leu8, Pro9NEt]-luteinizing hormone-releasing hormone (sGnRH-A), and [D-Ala6, Pro9NEt]-luteinizing hormone-releasing hormone (LHRH-A), in combination with pimozide, in stimulating gonadotropin release and ovulation in the goldfish, Carassius auratus (1987) (40)
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome. (1981) (40)
Chemical, biological, and immunological characterization of mono- and diiodothyrotropin releasing factor. (1976) (40)
Corticotropin-releasing factor receptor type 1 and 2 mRNA expression in the rat anterior pituitary is modulated by intermittent hypoxia, cold and restraint (2004) (40)
(Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF. (1972) (40)
Characterization of human anti-luteinizing hormone-releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH. (1981) (40)
NMR Structure of the First Extracellular Domain of Corticotropin-releasing Factor Receptor 1 (ECD1-CRF-R1) Complexed with a High Affinity Agonist* (2010) (39)
Activin-A in myometrium: characterization of the actions on myometrial cells. (2008) (39)
Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. (2007) (39)
Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics. (1993) (39)
The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin-releasing hormone in hypogonadal and cycling women. (1988) (39)
Hormonal Effects of Danazol and Medical Oophorectomy in Endometriosis (1983) (39)
Down-regulation of growth hormone releasing factor receptors following continuous infusion of growth hormone releasing factor in vivo. (1986) (39)
Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. (2001) (39)
Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease (1987) (39)
Gastric hypersecretion by intracisternal TRH: dissociation from hypophysiotropic activity and role of central catecholamine. (1985) (39)
Pituitary Response to Growth Hormone–Releasing Hormone in IDDM: Abnormal Responses to Insulin and Hyperglycemia (1992) (38)
Synthetic corticotropin-releasing factor stimulates secretion of immunoreactive β-endorphin/β-lipotropin and ACTH by human fetal pituitaries in vitro (1983) (38)
Erratum to “Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan” [Mol. Cell. Endocrinol. 180 (2001) 47–53] (2002) (38)
Growth hormone releasing factor (GRF) and dopamine coexist in hypothalamic arcuate neurons. (1985) (38)
TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways. (1989) (38)
Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats (2000) (38)
[Molecular structure of the hypothalamic factor (LRF) of ovine origin monitoring the secretion of pituitary gonadotropic hormone of luteinization (LH)]. (1971) (38)
Acromegaly from ectopic growth hormone‐releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long‐acting somatostatin analogue SMS 201–995 (1988) (38)
Partial retro-inverso analogues of somatostatin: pairwise modifications at residues 7 and 8 and at residues 8 and 9. (1985) (38)
Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. (1991) (38)
Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycle. (1988) (38)
The hypothalamic hypophysiotropic thyrotropin-releasing factor. (1971) (37)
Chronic Activation of Corticotropin-Releasing Factor Type 2 Receptors Reveals a Key Role for 5-HT1A Receptor Responsiveness in Mediating Behavioral and Serotonergic Responses to Stressful Challenge (2012) (37)
Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. (1998) (37)
Synthetic human pancreatic growth hormone releasing factor (GRF) stimulates growth hormone secretion in the domestic fowl (Gallus domesticus). (1984) (37)
Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. (1990) (37)
Effects of lesions in the periventricular nucleus of the preoptic-anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin (1981) (36)
Chronic effects of [D-Trp6,Pro9-NEt]luteinizing hormone-releasing factor on reproductive processes in the male rat. (1979) (36)
Presence of growth hormone-releasing factor-like immunoreactivity in rat duodenum. (1985) (36)
An endogenous ligand of the brain σ/PCP receptor antagonizes NMDA-induced neurotransmitter release (1987) (36)
Alcohol-induced inhibition of LH secretion in intact and gonadectomized male and female rats: possible mechanisms. (1992) (36)
Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. (1981) (36)
Transforming Growth Factor-β: Role in Mediating Serum-Induced Endothelin Production by Vascular Endothelial Cells* (1991) (36)
Analogs of luteinizing hormone releasing factor (LRF) synthesis and biological activity of [(Nα-Me)Leu7]LRF and [D-Ala6,(Nα-Me)Leu7]LRF (1975) (36)
Actions of Activins, Inhibins and Follistatins: Implications in Anterior Pituitary Function (2001) (36)
Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus (1993) (36)
Calcitonin COOH-terminal cleavage peptide as a model for identification of novel neuropeptides predicted by recombinant DNA analysis. (1982) (35)
Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. (1974) (35)
Facilitation of sexual receptivity in the female rat by a fragment of the LHRH decapeptide, Ac-LHRH. (1983) (35)
Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat (1991) (35)
Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal Men. An Approach Toward the Development of a Male Contraceptive (1982) (35)
Effects of Synthetic Corticotropin-Releasing Factor and Dopamine on the Release of Immunoreactive β-Endorphin/β-Lipotropin and α-Melanocyte-Stimulating Hormone from Human Fetal Pituitaries in Vitro* (1982) (35)
Impaired FSHbeta expression in the pituitaries of Foxl2 mutant animals. (2011) (35)
Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala (2013) (34)
Differential suppression of FSH and LH secretion by follicular fluid in the presence or absence of GnRH. (1984) (33)
Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp. (2014) (33)
Urotensin I - a novel CRF-like peptide in Catostomus commersoni urophysis. (1982) (33)
Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma. (1978) (33)
Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat. (1991) (33)
Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. (1990) (33)
Somatostatin desensitization in rat anterior pituitary cells (1984) (32)
[28] Assay of growth hormone-releasing factor (1986) (32)
Neuroendocrine Regulation of Reproduction (1990) (32)
A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. (2003) (31)
Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells. (2003) (31)
Receptor Serine Kinases and Signaling by Activins and Inhibins (1997) (31)
Immediate and Sustained Blood Pressure Lowering by Urocortin 2: A Novel Approach to Antihypertensive Therapy? (2009) (31)
A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene* (2008) (31)
Interleukin 1 prevents loss of corticotropic responsiveness to beta-adrenergic stimulation in vitro. (1988) (31)
Design of potent cyclic gonadotropin releasing hormone antagonists. (1988) (31)
Sequence analysis of rat hypothalamic corticotropin-releasing factor with the o-phthalaldehyde strategy. (1983) (30)
Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. (1994) (30)
Characterization of the extracellular ligand-binding domain of the type II activin receptor. (1998) (30)
Characterization of a sheep brain corticotropin releasing factor binding protein (1996) (30)
Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat. (1987) (30)
Effect of long-term infusion of ovine corticotrophin-releasing factor in the immature ovine fetus. (1986) (29)
The inhibitory effect of hormones associated with stress on Na appetite of sheep. (2000) (29)
Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy. (1997) (29)
Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala (1999) (29)
Pituitary responses to synthetic corticotropin-releasing hormone: absence of modulatory effects by estrogen and progestin. (1987) (29)
Inhibin, Activin and Follistatin (1997) (29)
A novel corticotropin‐releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress‐induced heart disease (2009) (28)
Effect of an LHRH agonist on pituitary and testicular function in rhesus monkeys. (1984) (28)
Circulating inhibin alpha concentrations in infant, prepubertal, and adult male rhesus monkeys (Macaca mulatta) and in juvenile males during premature initiation of puberty with pulsatile gonadotropin-releasing hormone treatment. (1989) (28)
In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release. (1989) (28)
Comparison of the effect of several gonadotropin releasing hormone antagonists on luteinizing hormone secretion, receptor binding and ovulation. (1983) (28)
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. (1994) (28)
Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets. (2011) (28)
Effect of Chronic Treatment with Thyrotropin-Releasing Hormone (TRH) or an Analog of TRH (Linear β-Alanine TRH) on the Hypothalamic-Pituitary-Thyroid Axis (1980) (28)
Growth Hormone and Prolactin Secretion in Hypophysial Stalk-Transected Pigs as Affected by Growth Hormone and Prolactin-Releasing and Inhibiting Factors (1991) (28)
Corticotropin-releasing factor binding protein dimerizes after association with ligand. (1994) (27)
Effects of Low Dose Ovine Corticotropin-Releasing Hormone in Humans: Endocrine Relationships and β: Endorphin/β-Lipotropin Responses* (1988) (27)
Characterization of the glucose-dependent release of growth hormone-releasing factor and somatostatin from superfused rat hypothalami. (1990) (27)
Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion. (1974) (27)
Interleukin-1β Regulates Pituitary Follistatin and Inhibin/Activin βB mRNA Levels and Attenuates FSH Secretion in Response to Activin-A. (1998) (26)
Protooncogene junB as a target for activin actions. (1993) (26)
Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties. (1991) (26)
Acute ovarian responses to a long-acting agonist of gonadotropin-releasing hormone in ovulatory women and women with polycystic ovarian disease. (1985) (26)
Effect of gonadotropin-releasing hormone antagonists on serum follicle-stimulating hormone and luteinizing hormone under conditions of singular follicle-stimulating hormone secretion. (1985) (26)
Microsequence Analysis of Proteins Purified by Gel Electrophoresis (1991) (26)
Synthesis and conformations of hypothalamic hormone releasing factors: two QRF-analogues containing backbone N-methyl groups (1975) (26)
Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly. (1988) (26)
Inhibin, activin, and follistatin : regulatory functions in system and cell biology (1997) (26)
High-performance liquid chromatographic purification of peptide hormones: ovine hypothalamic amunine (corticotropin releasing factor). (1982) (26)
In vitro pituitary hormone secretion assay for hypophysiotropic substances. (1975) (25)
Effects of gonadotropin releasing hormone agonists and antagonists on reproductive functions. (1983) (25)
Assignment of disulfide bonds in corticotropin-releasing factor-binding protein. (1994) (25)
Direct inhibition of testicular steroidogenesis and gonadotrophin receptor levels by [(imBzl)-D-His6, Pro9-NEt]GnRH and [D-Trp6, Pro9-NEt]GnRH, potent agonists of GnRH. (1982) (25)
Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men. (1990) (25)
Structure-activity relationships of somatostatin analogs in the rabbit ileum and the rat colon. (1983) (25)
Inhibin secretion during the rat estrous cycle: relationships to FSH secretion and FSH beta subunit mRNA concentrations. (1990) (25)
Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration. (1988) (25)
Intrapituitary cell-cell communication regulates ACTH secretion. (1989) (25)
Phosphorylation regulation of the interaction between Smad7 and activin type I receptor (2002) (25)
Growth-hormone-releasing factor. (1983) (24)
Activin and inhibin binding to the soluble extracellular domain of activin receptor II. (1999) (24)
Synthesis and biological activities of pseudopeptide analogues of LH-RH: agonists and antagonists. (1980) (24)
Somatostatin analogs with selected biologic activities. (1976) (24)
Immunoreactive inhibin secretion by the hypophysectomized female rat: demonstration of the modulating effect of gonadotropin-releasing hormone and estrogen through a direct ovarian site of action. (1989) (24)
Differential activation of type I and type II 3',5'-cyclic adenosine monophosphate-dependent protein kinases by growth hormone-releasing factor. (1987) (24)
Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men. (1987) (24)
Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone. (1986) (24)
Modulatory Actions of Corticotropin‐releasing Factor–binding Protein a (1996) (24)
The antiandrogenic action of gonadotropin-releasing hormone and its agonists on the mouse kidney. (1982) (23)
Synthetic luteinizing hormone releasing factor. Short chain analogs. (1974) (23)
The effects of corticotrophin‐releasing factor and two antagonists on breathing movements in fetal sheep. (1990) (23)
Antagonism of central growth hormone-releasing factor activity selectively attenuates dark-onset feeding in rats (1991) (23)
The effect of intravenous, subcutaneous, and intranasal GH‐RH analog, [Nle27]GHRH(1–29)‐NH2, on growth hormone secretion in normal men: Dose‐response relationships (1986) (23)
Human pancreatic growth hormone releasing factor (hpGRF-1-40) stimulates GH release in the ovine fetus. (1984) (23)
Ingestive responses to administration of stress hormones in baboons. (2002) (23)
Identification of a Single Melanin‐Concentrating Hormone Messenger Ribonucleic Acid in Coho Salmon: Structural Relatedness with 7SL Ribonucleic Acid (1991) (23)
Inhibin Structure and Function in the Testis a (1989) (23)
The elucidation of the primary structure of the hypothalamic thyroid stimulating hormone releasing factor of ovine origin by means of mass spectrometry (1971) (22)
Control of Anterior Pituitary Hormone Secretion (1974) (22)
Effect of GnRH antagonist, [Ac-delta 3Pro1, pFDPhe2, DTrp3,6] GnRH, on pulsatile gonadotrop in secretion in the castrate male primate. (1983) (22)
Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone. (1984) (22)
Medianosomes as integrative units in the external layer of the median eminence. Studies on grf/catecholamine and somatostatin/catecholamine interactions in the hypothalamus of the male rat (1986) (22)
Centrally administered hypothalamic growth hormone-releasing factor stimulates food intake in free-feeding rats (1988) (22)
Temporal relationship between the abortifacient effects of GnRH antagonists and hormonal secretion. (1981) (22)
Characterization and regulation of corticotropin-releasing factor in the human hepatoma NPLC-KC cell line. (1993) (22)
Suppressive actions of a gonadotropin-releasing hormone antagonist on luteinizing hormone, follicle-stimulating hormone, and prolactin release in estrogen-deficient postmenopausal women. (1990) (22)
Growth hormone-releasing factor secretion from fetal hypothalamic cell cultures is modulated by forskolin, phorbol esters, and muscimol. (1989) (21)
Activin Increases Phosphorylation and Decreases Stability of the Transcription Factor Pit-1 in MtTW15 Somatotrope Cells (*) (1995) (21)
Roles of activin family in pancreatic development and homeostasis (2012) (21)
Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. (2000) (21)
Dose relationship between GnRH antagonists and pituitary suppression. (1996) (21)
Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women. (1992) (21)
Tyrosylated analogues of somatostatin. (1976) (21)
An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties* (2005) (20)
Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation. (1999) (20)
Cocaine- and amphetamine-regulated transcript is localized in pituitary lactotropes and is regulated during lactation. (2006) (20)
Effects of Mammalian and Salmon Gonadotropin-Releaslng Hormones and Analogues on Plasma Gonadotropin Levels and Ovulation in Coho Salmon (Oncorhynchus kisutch) (1987) (20)
Inhibin: role and secretion in the rat. (1990) (20)
Solubilization of the gonadotropin-releasing hormone receptor from bovine pituitary plasma membranes. (1983) (20)
Molecular and functional characterization of activin receptors. (1993) (20)
Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs (1982) (19)
Photoperiod-mediated increases in serum concentrations of inhibin, follicle-stimulating hormone, and luteinizing hormone are accentuated in adult shortened-scrotum rams without corresponding decreases in testosterone and estradiol. (1993) (19)
Nucleotide regulation of growth hormone-releasing factor binding to rat pituitary receptors. (1989) (19)
The Local Control of the Pituitary by Activin Signaling and Modulation. (2011) (19)
Effect of synthetic ovine corticotropin-releasing factor: Prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol (1984) (19)
Interaction of adenosine 3',5'-monophosphate derivatives with the gonadotropin-releasing hormone receptor on pituitary and ovary. (1982) (19)
In vivo and in vitro effects of tetrahydroisoquinolines and other alkaloids on rat pituitary function. (1982) (19)
LHRH analogs as antiovulatory agents (1984) (19)
The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors. (2006) (19)
CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells (2014) (19)
Distinct Structural and Functional Roles of Conserved Residues in the First Extracellular Domain of Receptors for Corticotropin-releasing Factor and Related G-protein-coupled Receptors* (2007) (19)
Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies. (1998) (18)
Release of TSH by oral administration of synthetic peptide derivatives with TRF activity. (1970) (18)
Studies of the inhibin family of hormones: a review. (1987) (18)
Control of Voltage-gated Potassium Channel Kv2.2 Expression by Pyruvate-Isocitrate Cycling Regulates Glucose-stimulated Insulin Secretion* (2013) (18)
Thyroid hormones reversibly suppress somatostatin secretion and immunoreactivity in cultured neocortical cells (1985) (18)
Immunolocalization of inhibin alpha-subunit in the human testis. A light- and electron-microscopy study. (1992) (17)
Clinical studies with GHRH in man. (1986) (17)
Effects of spaceflight on hypothalamic peptide systems controlling pituitary growth hormone dynamics. (1992) (17)
Possible involvement of inhibin in altered follicle-stimulating hormone (FSH) secretion during dissociated luteinizing hormone (LH) and FSH release: unilateral castration and experimental cryptorchidism. (1989) (17)
300 – ACTIONS OF NEUROTENSIN UPON SINGLE NEURONE ACTIVITY IN DIFFERENT REGIONS OF THE RAT BRAIN (1978) (17)
Activin A/Bone Morphogenetic Protein (BMP) Chimeras Exhibit BMP-like Activity and Antagonize Activin and Myostatin* (2008) (17)
Analogues of luteinizing hormone releasing factor modified at positions 2, 6, and 10. (1976) (17)
Species differences in the sensitivity to the antitesticular effects of [Ac-D-NAL(2)1, 4FD-Phe2, D-Trp3,D-Arg6]-LHRH, a potent LHRH antagonist. (1984) (17)
Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding. (1993) (17)
Somatostatin analogs as glucagon suppressants in diabetes. (1978) (17)
Effects of Growth Hormone-Releasing Factor and Somatostatin on Growth Hormone Secretion in Hypophysial Stalk-Transected Beef Calves 1 (1988) (17)
Nature of ligand affinity and dimerization of corticotrophin-releasing factor-binding protein may be detected by circular dichroism. (1996) (17)
Structural modifications of non-mammalian gonadotropin-releasing hormone (GnRH) isoforms: design of novel GnRH analogues (1995) (16)
Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges. (1998) (16)
Reversal of the inhibition of TSH secretion due to acute stress. (1967) (16)
Effects of neurotensin and substance P on insulin and glucagon release by the perfused dog pancreas [proceedings]. (1976) (16)
Effect of recombinant inhibin on follicle-stimulating hormone secretion by the female rat: interaction with a gonadotropin-releasing hormone antagonist and estrogen. (1991) (16)
Cognitive Corticotropin-Releasing Factor Receptors CRF 1 and CRF 2 Exert Both Additive and Opposing Influences on Defensive Startle Behavior (2004) (16)
Effect of recombinant human inhibin on gonadotropin secretion by the male rat. (1991) (16)
Pharmacology of gonadotropin releasing hormone: a model regulatory peptide. (1981) (16)
UROCORTIN STIMULATES PLACENTAL ADRENOCORTICOTROPIN AND PROSTGLANDIN RELEASE AND MYOMETRICAL CONCTRACTILY (1999) (15)
Erratum: Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP) (Genomics (1993) 16 (63-68)) (1994) (15)
Neurobiological actions of cysteamine. (1985) (15)
DOSE RESPONSE OF PLASMA ADRENOCORTICOTROPIN AND CORTISOL (1983) (15)
Growth hormone response to growth hormone releasing factor in Alzheimer's disease. (1989) (15)
Release of TSH by TRF infused directly into a pituitary stalk portal vessel. (1971) (15)
De Novo Design and Synthesis of Somatostatin Non‐Peptide Peptidomimetics Utilizing β‐D‐Glucose as a Novel Scaffolding. (1994) (15)
Activation of ganglionic tyrosine hydroxylase by peptides of the secretin-glucagon family: Structure-function studies (1989) (15)
Speculations on structural relationships between the hypothalamic releasing factors of pituitary hormones. (1972) (14)
Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle. (2011) (14)
Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man (1987) (14)
Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep. (2004) (14)
CHARACTERIZATION OF MAMMALIAN MELANIN CONCENTRATING HORMONES AND THEIR PRECURSORS (1989) (14)
Neurobiology of peptides. (1978) (13)
Culture of enzymatically dispersed pituitary cells: functional validation of a method. (1972) (13)
Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. (2002) (13)
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. (1972) (13)
Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges. (1998) (13)
CRFR1 activation protects against cytokine-induced β-cell death. (2014) (13)
The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor (1994) (12)
Nonpeptidal Peptidomimetics with a β‐D‐Glucose Scaffolding. A Partial Somatostatin Agonist Bearing a Close Structural Relationship to a Potent, Selective Substance P Antagonist. (1993) (12)
Concomitant release of FSH and LH induced by native and synthetic LRF. (1973) (12)
Somatostatin: central nervous system (CNS) action on glucoregulation. (1978) (12)
Interleukin-1beta regulates pituitary follistatin and inhibin/activin betaB mRNA levels and attenuates FSH secretion in response to activin-A. (1998) (12)
Peptide N-alkylamides by solid phase synthesis. (2009) (12)
Effects of follicle-stimulating hormone on inhibin release by different testicular compartments in the adult ram. (1992) (12)
CRF receptors in the rodent and human cardiovascular systems: Species differences (2006) (12)
Effect of the LRF-antagonist [D-pGlu1, D-Phe2, D-Trp3,6]-LRF on pregnancy in the rat. (1979) (12)
LHRH in hypogonadotropic hypogonadism. (1981) (11)
Birth, Distress and Disease: Placental expression of neurohormones and other neuroactive molecules in human pregnancy (2005) (11)
Myelin basic protein: a substance that releases immunoreactive growth hormone in vitro. (1976) (11)
4 Activins and Inhibins (2008) (11)
Interaction of gonadotropin-releasing hormone agonist and antagonist with progesterone, prolactin, or human chorionic gonadotropin during pregnancy in the rat. (1982) (11)
Superfusion of Dissociated Pancreatic Islet Cells Attached to Cytodex Beads (1982) (11)
Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. (2001) (11)
Biological assays utilized to characterize LHRH and its analogs (1984) (11)
Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men. (1990) (11)
Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies. (1990) (11)
Inhibition of estradiol-induced gonadotropin release in ovariectomized rhesus macaques by a gonadotropin-releasing hormone antagonist. (1986) (11)
Expression and Functional Characterization of Membrane-Integrated Mammalian Corticotropin Releasing Factor Receptors 1 and 2 in Escherichia coli (2014) (11)
Somatostatin secretion from the hypothalamus. (1985) (11)
Hypothalamic Grafts and Neuroendocrine Cascade Theories of Aging (1984) (10)
Human endometrium expresses urocortin II and III messenger RNA and peptides. (2006) (10)
Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men. (1982) (10)
cDNA sequence of salmon melanin-concentrating hormone exhibits similarities with 7SL RNA. (1989) (10)
Solid Phase Synthesis of Amunine (CRF), Sauvagine and Two Urotensin I (1983) (10)
Fluorescent and cytotoxic analogs of corticotropin-releasing factor: probes for studying target cells in heterogeneous populations. (1989) (9)
Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone. (1974) (9)
Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions. (1999) (9)
Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products. (2013) (9)
Cyclic hexapeptides related to somatostatin. Synthesis and biological testing. (2009) (9)
Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides. (1974) (9)
Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion (1992) (9)
Effects of gamma-aminobutyric acid and histamine on prolactin secretion in the rat. (1977) (8)
[21] Methodological considerations in culturing peptidergic neurons (1983) (8)
Effects of human pancreatic and rat hypothalamic growth hormone-releasing factors on growth hormone secretion in steers☆☆☆ (1986) (8)
Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal women. (1984) (8)
An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH. (1973) (8)
Assay of growth hormone-releasing factor. (1986) (8)
Molecular characterization of rat transforming growth factor-beta type II receptor. (1993) (8)
Development of antibody to growth hormone-releasing factor. (1985) (7)
Periovulatory changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in hormonally induced immature female rats. (1989) (7)
Isolation, Amino‐Acid Sequence, Synthesis and Biological Properties of Urotensin I from Hippoglossoides elassodon (1990) (7)
Use of osmotic pumps for subcutaneous infusion of growth hormone-releasing factors in steers and wethers. (1988) (7)
Flow cytometric separation of gonadotrophs from dispersed rat pituitaries using a fluorescent GNRH antagonist (1983) (7)
Pituitary receptor binding assay of hypothalamic releasing factors. (1975) (7)
Micro-Sequence Analysis of Ovine Hypothalamic Corticotropin Releasing Factor (1982) (7)
Gastrin releasing peptide (GRP): Central nervous system (CNS) action to inhibit gastric secretion in rats (1980) (7)
Influence of ethanol on reproductive functions of the adult male rat as a function of body weight. (1983) (7)
Identification of Distinct Inhibin and Transforming Growth Factor β-binding Sites on Betaglycan (2006) (7)
Effect of a potent gonadotropin releasing hormone antagonist on pulsatile testosterone and gonadotropin secretion in the male nonhuman primate. (1984) (7)
Chemistry of hypothalamic releasing factors. (1973) (7)
Interaction of GnRH agonists, pituitary hormones and corticosteroids on progesterone secretion in the male rat. (1981) (6)
Stimulation of in-vivo growth hormone secretion in young chickens by rat hypothalamic growth hormone-releasing factor and synthetic analogues. (1986) (6)
Gamma-melanotropin response to ovine corticotropin releasing factor in normal humans (1987) (6)
Potent Long‐Acting Growth Hormone Releasing Factor Analogues 1 a (1988) (6)
On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide. (1972) (6)
Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor. (1971) (6)
Presence of calcium ions as a requisite for the in vitro stimulation of TSH-release by hypothalamic TRF (1967) (5)
The Disulfide Bond Arrangement in the Extracellular Domain of the Activin Type II Receptor (1999) (5)
Male contraception: Achievement of reversible azoospermia by combined gonadotropin releasing hormone antagonist and testosterone enanthate (1992) (5)
Immunolocalization of inhibin α-subunit in the human testis (1992) (5)
Activins and inhibins: Physiological roles, signaling mechanisms and regulation (2005) (5)
Local anesthetics inhibit veratridine-induced secretion of calcitonin gene-related peptide (CGRP) from cultured rat trigeminal ganglion cells (1986) (5)
Analogs of luteinizing hormone releasing factor (LRF). Synthesis and biological activity of ((Nalpha-Me)Leu-7)LRF and (D-Ala-6,(Nalpha-Me)Leu-7)LRF. (1975) (5)
Isolation and characterization of hypothalamic peptide hormones. (1976) (5)
Single dose responses to the gonadotropin-releasing hormone agonist analogue [(imBz 1)-D-His6,Pro9-NEt]GnRH. (1986) (5)
Growth hormone releasing factor and somatomedin C production: extrahypothalamic localization and possible functional significance. (1986) (5)
[Synthetic polypeptide derivatives with TRF hypophysiotropic activity. New data]. (1969) (5)
Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs. (1975) (5)
Expression of urocortin peptides in canine myocardium and plasma. (2011) (5)
A 90-Day Subcutaneous Toxicity and Fertility Study of a LHRH Antagonist in Rats (1990) (5)
Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors. (1973) (4)
[Synthetic polypeptide derivatives with thyrotropin releasing factor hypophysiotropic activity]. (1969) (4)
Effects of synthetic corticotropin-releasing factor and dopamine on the release of immunoreactive beta-endorphin/beta-lipotropin and alpha-melanocyte-stimulating hormone from human fetal pituitaries in vitro. (1982) (4)
4 – RECOVERY OF BIOLOGICAL ACTIVITY, BLOTTING AND SEQUENCE ANALYSIS OF PROTEIN HORMONES AFTER SDS-PAGE1 (1989) (4)
Characterization of a sheep brain corticotropin releasing factor binding protein (Brain Research 709 (1996) 265-274) (BRES 11959). (1996) (4)
Synthetic corticotropin-releasing factor stimulates secretion of immunoreactive beta-endorphin/beta-lipotropin and ACTH by human fetal pituitaries in vitro. (1983) (4)
The induction of premature luteolysis in normal women--follicular phase luteinizing hormone secretion and corpus luteum function in the subsequent cycle. (1991) (4)
A 90-day subcutaneous toxicity and fertility study of a LHRH antagonist in rats. (1990) (4)
Corticotropin-Releasing Hormone Receptor Signaling (2003) (4)
[Solid-phase total synthesis of a tetradecapeptide having the chemical and biological properties of somatostatine]. (1973) (3)
Lack of effect of native or synthetic LRF on secretion of prolactin in vitro. (1973) (3)
The Physiology of Human Growth: Growth hormone and growth hormone releasing hormone (1989) (3)
Effects of somatostatin antiserum on growth hormone levels in rats with periventricular lesions in the anterior hypothalamus (1988) (3)
Pituitary Desensitization with a Long-Acting Luteinizing-Hormone-Releasing Hormone Analog (1983) (3)
Growth hormone response to growth hormone-releasing factor in depression (1988) (3)
Effects of [d-Trp6,Pro9-NEt]-LHRH on reproductive functions in the male rat. (1980) (3)
The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin-releasing hormone in hypogonadal and cycling women (1989) (3)
Corticotropin-Releasing Hormone and Urocortins: Binding Proteins and Receptors (2009) (3)
Partial purification of inhibin from ovine rete testis fluid. (1986) (3)
Effects of low dose ovine corticotropin-releasing hormone in humans: endocrine relationships and beta-endorphin/beta-lipotropin responses. (1988) (3)
Therapeutic agents produced by genetic engineering: Quo vadis? The example of growth hormone and its releasing factor. Satellite symposium. Toulouse-Labège, May 29-30, 1985. (1986) (3)
Experiment K-6-22. Growth hormone regulation, synthesis and secretion in microgravity. Part 1: Somatotroph physiology. Part 2: Immunohistochemical analysis of hypothalamic hormones. Part 3: Plasma analysis (1990) (3)
beta-Endorphin modulates the inhibitory action of corticotropin-releasing factor on luteinizing hormone secretion. (1986) (3)
Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man. (1994) (3)
The role of peptide backbone modifications in increasing biological stability of LHRH analogs. (1981) (3)
3D NMR structure of the first extracellular domain of CRFR-2beta, a type B1 G-protein coupled receptor (2004) (3)
CHAPTER 4 – Hypothalamic Hormones (1975) (3)
SYNTHETIC LUTEINIZING HORMONE RELEASING FACTOR, SHORT CHAIN ANALOGS (1974) (3)
Inhibin: measurement and role in the rat. (1987) (2)
Focus on TGF- b Signalling Pituitary actions of ligands of the TGF- b family: activins and inhibins (2006) (2)
Experiment K-7-22: Growth Hormone Regulation Synthesis and Secretion in Microgravity. Part 1; Growth Hormone Regulation Synthesis and Secretion in Microgravity (1994) (2)
Corticotropin-releasing factor receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (2)
Hormonal regulation of gene expression: regulation of growth hormone gene transcription by growth hormone releasing factor. (1985) (2)
Human Urocortin 2 (2008) (2)
Chemical, Anatomical, and Physiological Studies on Human Pancreatic and Rat Hypothalamic Growth Hormone-Releasing Factor (1986) (2)
Methodological considerations in culturing peptidergic neurons. (1983) (2)
IMMUNOLOGICAL, ENZYMOLOGICAL AND CHEMICAL CHARACTERIZATION OF A LARGE SOMATOSTATIN-LIKE POLYPEPTIDE 1 (1980) (2)
Characterization of the N-Linked Glycan of Recombinantly-Expressed Corticotropin Releasing Factor Binding Protein (2000) (2)
SOMATOSTATIN ANALOGS, RELATIVE IMPORTANCE OF THE DISULFIDE BRIDGE AND OF THE ALA‐GLY SIDE CHAIN FOR BIOLOGICAL ACTIVITY (1975) (2)
High-Performance Liquid Chromatographic Purification of Peptide Hormones: Ovine Hypothalamic Amunine (Corticotropin Releasing Factor)1 (1983) (2)
Gonadotropin-releasing hormone antagonists containing novel amino acids (1994) (2)
Expression of urocortins in canine myocardium and plasma levels in dogs with cardiac disease (2010) (2)
Human pancreatic tumor GH-releasing factor (2005) (2)
Purification amino acid composition and N-terminus of the luteinizing hormone releasing factor (LRF) of ovine origin with recent studies on its biological activity. (1972) (2)
Potassium-induced stimulation of thyrotropin release in vitro. Requirement for presence of calcium and inhibition by thyroxine (1967) (2)
Cyclic analogs of [MeTyr 1,Ala 15,Nle27]GRF(1-29)-NH2 with high potencies in vitro (1994) (2)
Effects of Purified Thyrotropin Releasing Factor (TRF) on Thyrotropin (TSH) Release and Pituitary Acid Phosphatase Activity (1967) (2)
Cytotoxic analog of corticotropin releasing factor crf selectively eliminates crf target cells (1987) (1)
Chemical modulation of regulatory peptides (1985) (1)
Clinical Pharmacology of LHRH Antagonists (1990) (1)
TYROSYLATED ANALOGUES OF SOMATOSTATIN (1976) (1)
Hormones in Pituitary Secretory Granules Functional Amyloids As Natural Storage of Peptide (2009) (1)
ANALOGUES OF LUTEINIZING HORMONE RELEASING FACTOR MODIFIED AT POSITIONS 2, 6, AND 10 (1976) (1)
Competitive antagonists of the corticotropin releasing factor (CRF) scanned with a i-(i+3) Glu Lys Bridge (2002) (1)
Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and insulin resistance on a high fat diet (2009) (1)
Conformationally altered fragments of rat GRF: VIP homologs, analogs or both? (1985) (1)
Inhibition of gonadotropin secretion in women by an antagonistic analog of gonadotropin releasing hormone (1982) (1)
Guiding principles applied in the design of GPCR-selective hypothalamic hormone agonists and antagonists (2006) (1)
Urocortin Is Not a Significant Regulator of Intermittent Electrofootshock-Induced Adrenocorticotropin Secretion in the Intact Male Rat* *This work was supported by NIH Grant DK-26741 and The Foundation for Research. (1999) (1)
Effects of Somatostatin on Flushing and Plasma Gastrointestinal Peptides in the Carcinoid Syndrome (1980) (1)
Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF. (1973) (1)
Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in man. (1988) (1)
Synthesis of a New Cyclic Gonadotropin Releasing Hormone (GnRH) Antagonist. (1988) (1)
EFFECTS OF GONADOTROPIN RELEASING HORMONE AGONISTS AND ANTAGONISTS ON REPRODUCTIVE FUNCTIONS (1984) (1)
Probing the GnRH receptor with linear and cyclic analogs (1993) (1)
Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. (1982) (1)
Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands. (1986) (1)
CHARACTERIZATION OF RAT HYPOTHALAMIC GROWTH HORMONE AND CORTICOTROPIN RELEASING FACTORS (1983) (1)
[Total synthesis by solid phase of a decapeptide stimulating the secretion of LH and FSH pituitary gonadotropins]. (1971) (1)
Growth hormone releasing factors stimulate in vitro pancreatic enzyme secretion (1984) (1)
Anxiolytic-like actions of a nonpeptide small molecule corticotropin-releasing factor1 receptor antagonist in CRF transgenic mice (2000) (1)
Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. (2000) (1)
Regulation of Adrenocorticotropic Hormone (ACTH) Secretion by Corticotropin-Releasing Factor (CRF) (2018) (1)
Peptides and proteins act as bridges between the immune and the endocrine systems (1992) (1)
Characterization of Gonadotropin Hormone-Releasing Hormone Analogs (1989) (0)
Therapeutic Effects of Growth Hormone Releasing Hormone (1988) (0)
Refined 3D NMR structure of ECD1 of mCRF-R2beta at pH 5 (2007) (0)
Growth Hormone Releasing Hormone: Therapeutic Potentials (1987) (0)
Modulation of Gonadotropin Secretion by Proteins of the Inhibin Family: Studies in the Female Rat (1992) (0)
The inhibin / activin family and pro-opiomelanocortin-derived peptides as intratesticular regulators of cellular function. (1991) (0)
Erratum: Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: Comparison with normal sheep (Journal of the American College of Cardiology (2002) 40 (1495-1505)) (2003) (0)
Abstract 670: Immediate And Sustained Blood Pressure Lowering by CRF-receptor Stimulation: A Novel Approach To Antihypertensive Therapy? (2007) (0)
Contents, Vol. 2, 1967 (1967) (0)
Primary structure of corticotropmi-releasing factor from ovine hypothalamus ( micro-sequence analysis / reverse-phase high-pressure liquid chromatography / dansylation / thermolysin / carboxypeptidase Y ) (0)
Synthetic grf peptide (1985) (0)
S-26-2 CNS roles of CRF and urocortin, their receptors and binding protein (1996) (0)
Erratum (1975) (0)
Abnormalities in corticotropin-releasing factor (CRF) in neurodegenerative diseases (2018) (0)
Water-soluble peptides affecting gonadal function ogfremgangsmaade for the preparation thereof (1980) (0)
rCRF and similar compounds. (1984) (0)
Erratum (1983) (0)
GROWTH HORMONE (GH) RELEASE IN CHILDREN WITH SHORT STATURE: STIMULATION BY HUMAN PANCREATIC TUMOR GROWH HORMONE RELEASING FACTOR-40 (hpGRF-40) (1984) (0)
lymphoma: preliminary observations combination chemotherapy on posttherapy fertility in male patients with Effect of a luteinizing hormone releasing hormone agonist given during (2011) (0)
Melanin Concentrating Hormone and dns expremieren these (1990) (0)
Gonadal Peptide Hormones Modulating FSH Secretion (1987) (0)
Contents, Vol. 2, 1971/72 (1971) (0)
Peptides hydrosolubles affectant la fonction gonadique (1980) (0)
125. Identification of a functional binding site on betaglycan for inhibin and TGFβ (2005) (0)
Corticotropin releasing factor binding sites in the rat brain (1984) (0)
CRFR2 Modulation of Stress-Induced Behavioral Adaptations: Site-Specific Over-Expression of Urocortin 3 in the Limbic System. (2010) (0)
Subject Index Vol. 50, 1989 (1989) (0)
Factor Gene Expression within the Paraventricular Nucleus of the Rat Hypothalamus (1993) (0)
Effect of Analogues of Somatostatin on Pancreatic and Gut Hormones and Growth Hormone in Man (1979) (0)
and beta cells. (2012) (0)
Subject Index, Vol. 28, 1987 (1987) (0)
Calcitonin gene related peptide: immunohistochemical localization, specific binding and biological actions in the pancreas (1985) (0)
Activation of ganglionic tyrosine hydroxylase by peptides of the glucagon-secretin family: Structure-function studies (1989) (0)
Method for producing a peptide compound and peptide intermediate for the implementation of the procedure (1982) (0)
Physiologic Effects of a Gonadotropin Releasing Hormone Antagonist in Normal Women (1990) (0)
CRFR1 selective ligand (2002) (0)
Human urocortin II, a novel CRF-related peptide, displays a selective CRF 2 receptor mediated action on gastric transit in rats (2001) (0)
Corticotropinauslösefaktor-binding protein (1992) (0)
Systematic lactam scan of hGRF 1-29-NH2 yields potent agonists and antagonists (2002) (0)
The corticotropin-releasing factor type 2 receptor selective ligand Urocortin 3 suppresses angiogenesis in vitro and in vivo (2007) (0)
Human Urocortin 3 (2008) (0)
Abstract 4394: Chronic Administration of Urocortin 2 Prevents the Development of Heart Failure in an Animal Model of Hypertensive Heart Disease (2008) (0)
SYNTHETIC LUTEINIZING HORMONE RELEASING FACTOR ANALOGS, SERIES OF SHORT-CHAIN AMIDE LRF HOMOLOGS CONVERGING TO THE AMINO TERMINUS (1973) (0)
Actions of GRF in Man (1987) (0)
Symposium on neuropeptides. (1980) (0)
Gonadotropin-Releasing Hormone Antagonists : Novel Members of the Azaline (2001) (0)
Competitive antagonists of peptide hormones (1987) (0)
GAMMA+lRLANOTROPIN RESPONSE TO OVINE CORTICOTROPIN RELEASING FACTOR IN NORHAL RDtUNS (1987) (0)
Ligands selectifs crfr1 (2002) (0)
Abstracts of Selected Free Communications (1986) (0)
Differential regulation of Urocortin 3 mRNA expression in the central nervous system by stress and glucocorticoids (2005) (0)
Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis. (1980) (0)
Distribution, metabolism, and pharmacology of peptides. (1978) (0)
GnRH antagonists: A synopsis (1992) (0)
3D NMR structure of ECD1 of mCRF-R2b in complex with Astressin (2007) (0)
Abstract 3493: Soluble ALK4 extracellular domain antagonizes the cancer/stem cell phenotype caused by Nodal and Cripto signaling in mammary epithelia (2012) (0)
27 Growth Hormone-Releasing Factor (1986) (0)
Experiment K-7-22: Growth Hormone Regulation Synthesis and Secretion in Microgravity. Part 2; Hypothalamic Growth Hormone-Releasing Factor, Somatostatin Immunoreactivity, and Messenger RNA Levels in Microgravity (1994) (0)
CHARACTERIZATION OF CORTICOTROPIN AND GROWTH HORMONE RELEASING FACTOR. (1983) (0)
Abstract 4006: Soluble ALK4 extracellular domain antagonizes oncogenic Cripto signaling and inhibits tumor growth (2010) (0)
Serum follistatin levels predict the extent of liver regeneration after hepatectomy in human and rat models (2004) (0)
Crystal structure of Bone Morphogenetic Protein-7 (BMP-7) in complex with the secreted antagonist Noggin (2002) (0)
Pharmacology of GnRH analogues (1985) (0)
SAR of corticotropin releasing factor in relation to its pituitary receptor and binding protein (1995) (0)
Serum follistatin level as an early detection marker of post-hepatectomy liver failure: Using our novel rat 90% hepatectomy model (2001) (0)
Structure activity relationships (SAR) of corticotropin releasing factor (1995) (0)
Human Urocortin 1 (2008) (0)
Fetal administration of cortioctropin-releasing factor (CRF) can induce premature parturition in sheep (1984) (0)
Growth-Hormone-Releasing Factor: Clinical Considerations (1987) (0)
Crystal structure of the activin/actrIIb extracellular domain (2004) (0)
Corticotropin releasing factor as a regulator of the synthesis and secretion of proopiomelanocortin (1984) (0)
Melanin concentrating hormone and DNA for the expression of the same (1990) (0)
Urocortinproteiner and uses thereof (2001) (0)
NMR Structure of the ECD1 of CRF-R1 in complex with a peptide agonist (2010) (0)
Short communication The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor (1994) (0)
Subject Index Vol. 36, 1983 (1983) (0)
List of Contributors and Discussants (1981) (0)
Corticotropin Releasing Factor/Urocortin Network of Ligands and Their Receptors (2008) (0)
Kageyama, K. et al. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140, 5651-558 (2000) (0)
Gonadotropin releasing hormone antagonists with acyl substitutions of 4-aminophenylalanine at positions 5 and 6 (1995) (0)
Role of Endogenous Corticotropin-Releasing Factor in Modulating the Pituitary Response to Stress (1989) (0)
Structurally constrained LHRH analogs (1984) (0)
CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE TYPE II ACTIVIN RECEPTOR (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wylie W. Vale?

Wylie W. Vale is affiliated with the following schools:

Yale University
Weizmann Institute of Science
University of Oxford
University of Melbourne
Vanderbilt University
Royal Postgraduate Medical School
University of Hamburg
University of Toronto
University of Copenhagen
University of Manchester

Wylie W. Vale's Academic­Influence.com Rankings

Wylie W. Vale's Degrees

Why Is Wylie W. Vale Influential?

Wylie W. Vale's Published Works

Published Works

What Schools Are Affiliated With Wylie W. Vale?

Wylie W. Vale's AcademicInfluence.com Rankings